John Daniel Kelly
NIH Rank #1136
- Program Leader
- Top 10% Funded
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12324122Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2026
Linked Award Amount
$3.5M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#1,136
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing John Daniel Kelly as a PI. Multi-PI records show the full award amount for context.
- 5U01EY038042-02U01Long-term ocular sequelae and biological determinants of post-acute Ebola virus disease$1.8Maward amount
- 1U01AI192043-01A1U01Early antiviral treatment to prevent viral persistence and inflammation as drivers of Long COVID: a proof-of-concept mechanistic trial$1.7Maward amount
Award organizations
Organizations that administered FY2026 awards listing John Daniel Kelly as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardNorthern California Institute/Res/Edu
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #7540
- 2026$2M Cumulative Funding
- 2026$5M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #1136
- 2026Entered Top 10% NationallyRanked #1136
- 2026Multi-Institutional ResearchAwards at 2 institutions
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as John Daniel Kelly.